8-epi-prostaglandin-f2alpha and Carotid-Artery-Diseases

8-epi-prostaglandin-f2alpha has been researched along with Carotid-Artery-Diseases* in 2 studies

Other Studies

2 other study(ies) available for 8-epi-prostaglandin-f2alpha and Carotid-Artery-Diseases

ArticleYear
Plaque regression in one artery is not necessarily associated with parallel changes in other vascular beds.
    Heart and vessels, 2011, Volume: 26, Issue:3

    It remains unclear whether atherosclerosis in one vascular bed progresses in parallel with that in other vascular beds. We investigated serial changes in vessel wall areas (VWAs) in various vessels over 2 years of follow-up. Vessel wall areas in the thoracic descending aorta (TDA), common carotid artery (CCA), right (RCA), and left main trunk (LMT) of coronary artery were determined in 52 patients with coronary artery disease (CAD) using 64-slice multidetector computed tomography. Plasma levels of high-sensitivity CRP (hs-CRP) and matrix metalloproteinase (MMP)-9, as well as urinary 8-iso-prostaglandin F2α (PGF2α) were determined at the baseline. After the follow-up period, plaque progression in a specific vessel did not parallel that of other vessels, although changes in TDA-VWAs were weakly correlated with those of LMT-VWAs. Basal levels of hs-CRP, MMP-9, and PGF2α did not predict progression or regression of VWAs in any vessels. Multivariate analyses showed that LDL-cholesterol < 100 mg/dl and use of statin emerged as predictors of regressing VWAs in TDA (p < 0.05 and p < 0.05, respectively) and LMT (p < 0.05 and p = 0.13, respectively). Changes in soft plaques over 2 years paralleled those of VWAs in both coronary arteries. In conclusion, the progression or regression of atherosclerotic plaques is inhomogeneous among the vascular beds of patients with CAD.

    Topics: Aged; Aorta, Thoracic; Aortic Diseases; Aortography; Atherosclerosis; Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Carotid Artery, Common; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Dinoprost; Disease Progression; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Logistic Models; Male; Matrix Metalloproteinase 9; Middle Aged; Time Factors; Tomography, X-Ray Computed

2011
Circulating oxidized low-density lipoprotein and its association with carotid intima-media thickness in asymptomatic members of familial combined hyperlipidemia families.
    Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:8

    Oxidized low-density lipoprotein (Ox-LDL)is implicated in the pathogenesis of atherosclerosis. Circulating oxidation-specific epitopes on plasma Ox-LDL has been linked with coronary artery disease, but its determinants and its association with early development of atherosclerosis in familial combined hyperlipidemia (FCHL) has not been very well studied. This study aimed to investigate the determinants of the circulating Ox-LDL and the association between Ox-LDL and carotid intima-media thickness (IMT) in asymptomatic members of FCHL families.. Ox-LDL, susceptibility of LDL to oxidation in vitro, plasma 8-isoprostane and antioxidants, lipids and lipoproteins, LDL particle size, and carotid IMT were measured in 150 asymptomatic FCHL family members. Affected FCHL family members had reduced LDL particle size and lag time for LDL oxidation, increased plasma levels of Ox-LDL, increased plasma urate and alpha-tocopherol, and a trend for the increase of 8-isoprostane as compared with nonaffected FCHL. Ox-LDL was independently associated with serum LDL cholesterol, apoB, and 8-isoprostane in multivariate analysis but only univariately correlated with LDL particle size and lag time for LDL oxidation. In addition, Ox-LDL was significantly associated with carotid mean IMT independently of other clinical and biochemical variables in a multivariate model.. Serum LDL cholesterol, apoB levels, and 8-isoprostane were the most important determinants of Ox-LDL. Ox-LDL is independently associated with carotid IMT in asymptomatic FCHL family members and can be used as a marker of early atherosclerosis in FCHL.

    Topics: Adult; Antioxidants; Biomarkers; Carotid Arteries; Carotid Artery Diseases; Dinoprost; Disease Susceptibility; Female; Finland; Humans; Hyperlipidemia, Familial Combined; Lipids; Lipoproteins; Lipoproteins, LDL; Male; Particle Size; Tunica Intima; Tunica Media; Ultrasonography

2004